Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; referees: 3 approved]
Background: Funding for neglected disease product development fell from 2009-2015, other than a brief injection of Ebola funding. One impediment to mobilizing resources is a lack of information on product candidates, the estimated costs to move them through the pipeline, and the likelihood of specif...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-08-01
|
| Series: | Gates Open Research |
| Online Access: | https://gatesopenresearch.org/articles/2-23/v2 |